Tralokinumab Promising for Moderate-to-Severe Atopic Dermatitis: 28-Week Real-World Study Results Medha Baranwal31 Dec 2024 8:45 PM ISTNetherlands: A recent study demonstrated that tralokinumab is an effective treatment for moderate-to-severe atopic dermatitis in adult patients,...
Tralokinumab beneficial for patients with prurigo nodularis-like phenotype atopic dermatitis: JAAD Medha Baranwal4 July 2023 9:15 AM ISTItaly: Tralokinumab, an IL-13 monoclonal antibody, showed clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis...
Tralokinumab and Topical Corticosteroids tied to sustained important in Atopic Dermatitis: ECZTRA 3 trial. Dr.Niharika Harsha B27 July 2022 7:00 PM ISTOver 32 weeks, it was found that continued use of tralokinumab treatment plus topical corticosteroids as needed provided progressive and sustained...
Tralokinumab associated with increased risk of conjunctivitis in severe AD: study Dr. Shravani Dali16 Nov 2021 9:00 AM ISTTreatment with tralokinumab was associated with an increased incidence of conjunctivitis, according to a recent study published in the British...
Tralokinumab, topical corticosteroids combination beneficial in Atopic dermatitis Dr. Nandita Mohan9 Nov 2021 5:41 PM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide....
Medical Bulletin 8/ November /2021 Dr. Nandita Mohan9 Nov 2021 11:53 AM ISTHere are Top Medical Stories of the dayTralokinumab, corticosteroids helpful in ADAtopic dermatitis (AD), is a common chronic or recurrent...
Tralokinumab plus topical corticosteroids effective in severe atopic dermatitis MD Editorial Team8 Nov 2021 9:00 AM ISTAtopic dermatitis (AD), is a common chronic or recurrent inflammatory skin disease and affects 15-20% of children and 1-3% of adults worldwide. ...
